The Elite Test Bank:
Medical-Surgical Nursing
(2026/2027 Professional Standard)
PART 0: THE NAVIGATOR
Section Cognitive Focus Question Range
I. Foundational Syntax & Hard Deck Definitions & Q1 – Q15
Application Protocol Parameters
II. Professional Simulation Acute Clinical Recognition & Q16 – Q40
Immediate Action
III. Grandmaster Synthesis Multi-System Crisis Aversion & Q41 – Q55
Prioritization
PART I: THE PRIMER
Mastering adult medical-surgical nursing requires abandoning academic memorization in favor
of rapid, evidence-based clinical intuition to avert failure to rescue. High-level professional
success demands the precise execution of life-saving interventions within high-stakes,
dynamically shifting physiological environments.
● Sepsis (2026): Abandon qSOFA; utilize dynamic fluid responsiveness; initiate peripheral
norepinephrine immediately if unresponsive.
● Stroke (2026): Tenecteplase (TNK) 0.25 mg/kg single IV bolus is the standard; blood
pressure must remain strictly <185/110 mmHg.
● Heart Failure (2026): Quadruple GDMT is mandatory (ARNI, Beta-Blocker, MRA,
SGLT2i).
● Diabetes (2026): Perioperative target is 100-180 mg/dL; elective surgery clearance
strictly requires an A1C ≤ 8%.
● Staffing (NPG 12): Delegation of clinical judgment is prohibited; registered nurse staffing
is an acuity-driven safety mandate governed by the nurse executive.
PART II: THE ELITE TEST BANK
Q1: Under the 2026 American Heart Association guidelines, a patient presenting with an
average blood pressure of 144/92 mmHg is classified as having Stage 2 Hypertension.
What is the immediate, guideline-directed pharmacological intervention? A) Initiate a
three-to-six-month trial of lifestyle modifications before prescribing medication. B) Prescribe a
single thiazide diuretic and schedule a follow-up in one month. C) Initiate treatment with two
first-line antihypertensive medications combined in a single pill. D) Prescribe an ACE inhibitor
and advise the patient to monitor blood pressure at home weekly.
● The Answer: C (Initiate treatment with two first-line antihypertensive medications
, combined in a single pill).
● Distractor Analysis: Option A applies strictly to low-risk Stage 1 hypertension where
lifestyle intervention serves as the initial therapy. Options B and D represent obsolete
monotherapy approaches that fail to meet the 2026 aggressive treatment standards for
Stage 2 hypertension, leading to prolonged vascular damage and target organ
hypertrophy.
● The Mentor's Analysis: The 2026 AHA guidelines mandate early and aggressive
intervention. For Stage 2 hypertension, defined as a blood pressure of 140/90 mmHg or
higher, initiating a two-drug combination in a single pill is the standard of care. This
protocol ensures rapid achievement of the <130/80 mmHg target while significantly
maximizing patient adherence through pill-burden reduction. The implementation of the
PREVENT calculator further refines this by assessing 10-year and 30-year cardiovascular
risks, pushing clinicians to avoid clinical inertia.
Q2: According to the KDIGO 2026 guidelines, which of the following objective findings
definitively confirms the onset of Acute Kidney Injury (AKI) in a postoperative patient? A)
An absolute increase in serum creatinine by 0.1 mg/dL within 24 hours. B) A decrease in urine
output to 0.4 mL/kg/h sustained for 6 hours. C) A serum potassium level rising from 4.2 to 5.1
mEq/L. D) A sustained mean arterial pressure (MAP) of 62 mmHg over 12 hours.
● The Answer: B (A decrease in urine output to 0.4 mL/kg/h sustained for 6 hours).
● Distractor Analysis: Option A does not meet the strict ≥0.3 mg/dL threshold required
within a 48-hour window. Option C is a potential downstream metabolic consequence of
AKI, not a primary diagnostic criterion. Option D describes a prerenal hemodynamic state
that may cause AKI, but it does not confirm intrinsic cellular injury.
● The Mentor's Analysis: Acute Kidney Injury diagnosis relies strictly on precise serum
creatinine or urine output metrics. A drop in urine output below 0.5 mL/kg/h for at least 6
hours is a highly sensitive, early indicator of declining glomerular filtration. Professional
intuition dictates treating isolated oliguria as an acute cellular injury until proven
otherwise, allowing for rapid fluid resuscitation or hemodynamic optimization to prevent
permanent nephron necrosis.
Q3: The 2026 GOLD Report reclassifies COPD patient groups to guide initial
pharmacological therapy. A patient with a history of two moderate exacerbations in the
past year and an eosinophil count of 350 cells/µL belongs to Group E. What is the
mandatory baseline therapy? A) Short-acting beta-agonist (SABA) as needed. B) Long-acting
muscarinic antagonist (LAMA) monotherapy. C) A combination of LABA and LAMA only. D) A
combination of LABA, LAMA, and an Inhaled Corticosteroid (ICS).
● The Answer: D (A combination of LABA, LAMA, and an Inhaled Corticosteroid (ICS)).
● Distractor Analysis: Option A is dangerously inadequate for frequent exacerbators and
represents a reactive rather than a proactive stance. Options B and C ignore the patient's
elevated eosinophil count, missing a critical pharmacological opportunity to suppress
targeted eosinophilic inflammation.
● The Mentor's Analysis: Group E is clinically defined by a high exacerbation risk profile.
The 2026 standard dictates that escalating to triple therapy, which includes an inhaled
corticosteroid, is required specifically when the peripheral blood eosinophil count is ≥300
cells/µL. This direct intervention halts the inflammatory cascade that drives recurrent
hospitalizations and irreversible pulmonary function decline.
GOLD 2026 Group Exacerbation History Recommended Initial Therapy
Group A 0-1 moderate exacerbations Bronchodilator (SABA or LABA)
, GOLD 2026 Group Exacerbation History Recommended Initial Therapy
(not leading to hospital
admission)
Group B 0-1 moderate exacerbations LABA + LAMA combination
(highly symptomatic)
Group E ≥ 2 moderate exacerbations LABA + LAMA (consider adding
OR ≥ 1 leading to hospital ICS if eosinophils ≥ 300)
admission
Q4: A patient with Type 1 Diabetes Mellitus is admitted for elective orthopedic surgery.
According to the 2026 American Diabetes Association (ADA) Standards of Care, what are
the strict parameters required to proceed with surgery and manage perioperative blood
glucose? A) A1C ≤ 8% prior to surgery; perioperative blood glucose maintained between
100-180 mg/dL. B) A1C ≤ 9% prior to surgery; perioperative blood glucose maintained below
110 mg/dL. C) No strict A1C requirement if the patient is fasting; intraoperative glucose > 200
mg/dL. D) A1C ≤ 7%; discontinuation of all basal insulin 24 hours prior to surgery.
● The Answer: A (A1C ≤ 8% prior to surgery; perioperative blood glucose maintained
between 100-180 mg/dL).
● Distractor Analysis: Option B introduces severe hypoglycemia risk by targeting <110
mg/dL in an unconscious or sedated patient. Option C guarantees poor wound healing,
severe immunosuppression, and increased infection risk. Option D will precipitate diabetic
ketoacidosis (DKA) due to total basal insulin deprivation in an insulin-dependent patient.
● The Mentor's Analysis: Surgical stress induces the massive release of
counter-regulatory hormones such as cortisol and epinephrine, causing profound
systemic hyperglycemia. The 2026 ADA standard explicitly defines an A1C threshold of
≤8% to authorize elective surgery. Furthermore, the perioperative target of 100-180 mg/dL
serves as the precise therapeutic window that balances the devastating risks of lethal
intraoperative hypoglycemia against postoperative surgical site infections and impaired
fibroblast activity.
Q5: The Joint Commission's 2026 National Performance Goal (NPG) 12 formally
categorizes nurse staffing as a critical safety mandate. When assigning tasks, which
action firmly violates the "Delegation Hard Deck"? A) Delegating the recording of strict
intake and output to an unlicensed assistive personnel (UAP). B) Assigning a licensed practical
nurse to administer oral antihypertensives to a stable patient. C) Delegating the initial evaluation
of a patient's response to a new intravenous opioid analgesic to a UAP. D) Instructing a UAP to
perform routine capillary blood glucose monitoring on a known diabetic patient.
● The Answer: C (Delegating the initial evaluation of a patient's response to a new
intravenous opioid analgesic to a UAP).
● Distractor Analysis: Options A and D involve standard, predictable data collection tasks
perfectly suited for UAPs. Option B falls cleanly within the standard scope of a licensed
practical nurse. Option C violently breaches the core legal principles of professional
nursing practice.
● The Mentor's Analysis: NPG 12 enforces that a registered nurse must never delegate
clinical judgment, the formulation of a care plan, or outcome evaluation. Evaluating the
physiological response to a high-alert medication requires the complex synthesis of
respiratory depth, neurological status, and hemodynamic parameters. This isolates the
task completely within the registered nurse's specialized domain.
Q6: A patient with Heart Failure with reduced Ejection Fraction (HFrEF) is being
Medical-Surgical Nursing
(2026/2027 Professional Standard)
PART 0: THE NAVIGATOR
Section Cognitive Focus Question Range
I. Foundational Syntax & Hard Deck Definitions & Q1 – Q15
Application Protocol Parameters
II. Professional Simulation Acute Clinical Recognition & Q16 – Q40
Immediate Action
III. Grandmaster Synthesis Multi-System Crisis Aversion & Q41 – Q55
Prioritization
PART I: THE PRIMER
Mastering adult medical-surgical nursing requires abandoning academic memorization in favor
of rapid, evidence-based clinical intuition to avert failure to rescue. High-level professional
success demands the precise execution of life-saving interventions within high-stakes,
dynamically shifting physiological environments.
● Sepsis (2026): Abandon qSOFA; utilize dynamic fluid responsiveness; initiate peripheral
norepinephrine immediately if unresponsive.
● Stroke (2026): Tenecteplase (TNK) 0.25 mg/kg single IV bolus is the standard; blood
pressure must remain strictly <185/110 mmHg.
● Heart Failure (2026): Quadruple GDMT is mandatory (ARNI, Beta-Blocker, MRA,
SGLT2i).
● Diabetes (2026): Perioperative target is 100-180 mg/dL; elective surgery clearance
strictly requires an A1C ≤ 8%.
● Staffing (NPG 12): Delegation of clinical judgment is prohibited; registered nurse staffing
is an acuity-driven safety mandate governed by the nurse executive.
PART II: THE ELITE TEST BANK
Q1: Under the 2026 American Heart Association guidelines, a patient presenting with an
average blood pressure of 144/92 mmHg is classified as having Stage 2 Hypertension.
What is the immediate, guideline-directed pharmacological intervention? A) Initiate a
three-to-six-month trial of lifestyle modifications before prescribing medication. B) Prescribe a
single thiazide diuretic and schedule a follow-up in one month. C) Initiate treatment with two
first-line antihypertensive medications combined in a single pill. D) Prescribe an ACE inhibitor
and advise the patient to monitor blood pressure at home weekly.
● The Answer: C (Initiate treatment with two first-line antihypertensive medications
, combined in a single pill).
● Distractor Analysis: Option A applies strictly to low-risk Stage 1 hypertension where
lifestyle intervention serves as the initial therapy. Options B and D represent obsolete
monotherapy approaches that fail to meet the 2026 aggressive treatment standards for
Stage 2 hypertension, leading to prolonged vascular damage and target organ
hypertrophy.
● The Mentor's Analysis: The 2026 AHA guidelines mandate early and aggressive
intervention. For Stage 2 hypertension, defined as a blood pressure of 140/90 mmHg or
higher, initiating a two-drug combination in a single pill is the standard of care. This
protocol ensures rapid achievement of the <130/80 mmHg target while significantly
maximizing patient adherence through pill-burden reduction. The implementation of the
PREVENT calculator further refines this by assessing 10-year and 30-year cardiovascular
risks, pushing clinicians to avoid clinical inertia.
Q2: According to the KDIGO 2026 guidelines, which of the following objective findings
definitively confirms the onset of Acute Kidney Injury (AKI) in a postoperative patient? A)
An absolute increase in serum creatinine by 0.1 mg/dL within 24 hours. B) A decrease in urine
output to 0.4 mL/kg/h sustained for 6 hours. C) A serum potassium level rising from 4.2 to 5.1
mEq/L. D) A sustained mean arterial pressure (MAP) of 62 mmHg over 12 hours.
● The Answer: B (A decrease in urine output to 0.4 mL/kg/h sustained for 6 hours).
● Distractor Analysis: Option A does not meet the strict ≥0.3 mg/dL threshold required
within a 48-hour window. Option C is a potential downstream metabolic consequence of
AKI, not a primary diagnostic criterion. Option D describes a prerenal hemodynamic state
that may cause AKI, but it does not confirm intrinsic cellular injury.
● The Mentor's Analysis: Acute Kidney Injury diagnosis relies strictly on precise serum
creatinine or urine output metrics. A drop in urine output below 0.5 mL/kg/h for at least 6
hours is a highly sensitive, early indicator of declining glomerular filtration. Professional
intuition dictates treating isolated oliguria as an acute cellular injury until proven
otherwise, allowing for rapid fluid resuscitation or hemodynamic optimization to prevent
permanent nephron necrosis.
Q3: The 2026 GOLD Report reclassifies COPD patient groups to guide initial
pharmacological therapy. A patient with a history of two moderate exacerbations in the
past year and an eosinophil count of 350 cells/µL belongs to Group E. What is the
mandatory baseline therapy? A) Short-acting beta-agonist (SABA) as needed. B) Long-acting
muscarinic antagonist (LAMA) monotherapy. C) A combination of LABA and LAMA only. D) A
combination of LABA, LAMA, and an Inhaled Corticosteroid (ICS).
● The Answer: D (A combination of LABA, LAMA, and an Inhaled Corticosteroid (ICS)).
● Distractor Analysis: Option A is dangerously inadequate for frequent exacerbators and
represents a reactive rather than a proactive stance. Options B and C ignore the patient's
elevated eosinophil count, missing a critical pharmacological opportunity to suppress
targeted eosinophilic inflammation.
● The Mentor's Analysis: Group E is clinically defined by a high exacerbation risk profile.
The 2026 standard dictates that escalating to triple therapy, which includes an inhaled
corticosteroid, is required specifically when the peripheral blood eosinophil count is ≥300
cells/µL. This direct intervention halts the inflammatory cascade that drives recurrent
hospitalizations and irreversible pulmonary function decline.
GOLD 2026 Group Exacerbation History Recommended Initial Therapy
Group A 0-1 moderate exacerbations Bronchodilator (SABA or LABA)
, GOLD 2026 Group Exacerbation History Recommended Initial Therapy
(not leading to hospital
admission)
Group B 0-1 moderate exacerbations LABA + LAMA combination
(highly symptomatic)
Group E ≥ 2 moderate exacerbations LABA + LAMA (consider adding
OR ≥ 1 leading to hospital ICS if eosinophils ≥ 300)
admission
Q4: A patient with Type 1 Diabetes Mellitus is admitted for elective orthopedic surgery.
According to the 2026 American Diabetes Association (ADA) Standards of Care, what are
the strict parameters required to proceed with surgery and manage perioperative blood
glucose? A) A1C ≤ 8% prior to surgery; perioperative blood glucose maintained between
100-180 mg/dL. B) A1C ≤ 9% prior to surgery; perioperative blood glucose maintained below
110 mg/dL. C) No strict A1C requirement if the patient is fasting; intraoperative glucose > 200
mg/dL. D) A1C ≤ 7%; discontinuation of all basal insulin 24 hours prior to surgery.
● The Answer: A (A1C ≤ 8% prior to surgery; perioperative blood glucose maintained
between 100-180 mg/dL).
● Distractor Analysis: Option B introduces severe hypoglycemia risk by targeting <110
mg/dL in an unconscious or sedated patient. Option C guarantees poor wound healing,
severe immunosuppression, and increased infection risk. Option D will precipitate diabetic
ketoacidosis (DKA) due to total basal insulin deprivation in an insulin-dependent patient.
● The Mentor's Analysis: Surgical stress induces the massive release of
counter-regulatory hormones such as cortisol and epinephrine, causing profound
systemic hyperglycemia. The 2026 ADA standard explicitly defines an A1C threshold of
≤8% to authorize elective surgery. Furthermore, the perioperative target of 100-180 mg/dL
serves as the precise therapeutic window that balances the devastating risks of lethal
intraoperative hypoglycemia against postoperative surgical site infections and impaired
fibroblast activity.
Q5: The Joint Commission's 2026 National Performance Goal (NPG) 12 formally
categorizes nurse staffing as a critical safety mandate. When assigning tasks, which
action firmly violates the "Delegation Hard Deck"? A) Delegating the recording of strict
intake and output to an unlicensed assistive personnel (UAP). B) Assigning a licensed practical
nurse to administer oral antihypertensives to a stable patient. C) Delegating the initial evaluation
of a patient's response to a new intravenous opioid analgesic to a UAP. D) Instructing a UAP to
perform routine capillary blood glucose monitoring on a known diabetic patient.
● The Answer: C (Delegating the initial evaluation of a patient's response to a new
intravenous opioid analgesic to a UAP).
● Distractor Analysis: Options A and D involve standard, predictable data collection tasks
perfectly suited for UAPs. Option B falls cleanly within the standard scope of a licensed
practical nurse. Option C violently breaches the core legal principles of professional
nursing practice.
● The Mentor's Analysis: NPG 12 enforces that a registered nurse must never delegate
clinical judgment, the formulation of a care plan, or outcome evaluation. Evaluating the
physiological response to a high-alert medication requires the complex synthesis of
respiratory depth, neurological status, and hemodynamic parameters. This isolates the
task completely within the registered nurse's specialized domain.
Q6: A patient with Heart Failure with reduced Ejection Fraction (HFrEF) is being
